← Open Payments lookup

MELISSA KONKEN: Open Payments

NPI 1902358443 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,416 in 205 payments from 14 companies in 2025. Trend: 2023 $2,913 · 2024 $2,957 · 2025 $3,416

Food & beverage: $3,416
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.25$485
Alkermes, Inc.24$473
E.R. Squibb & Sons, L.L.C.24$461
Corium, LLC22$317
Vanda Pharmaceuticals Inc.16$304
Neurocrine BioSciences, Inc.24$290
ABBVIE INC.25$268
Teva Pharmaceuticals USA, Inc.14$263
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$240
Janssen Pharmaceuticals, Inc1$115

Products named: REXULTI, COBENFY, ARISTADA, Azstarys, INGREZZA, VRAYLAR, CAPLYTA, FANAPT.

Industry payments across IA — which companies pay providers there.